Showing results (1-10 of 65) with videos related to
Sort By:
Pageof 7
Neuro-Oncology|August 21, 2015
Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complexJeffrey P MacKeigan, Darcy A KruegerAntioxidants & Redox Signaling|October 24, 2012
Mitochondrial phosphorylation in apoptosis: flipping the death switchNatalie M Niemi, Jeffrey P MacKeiganFuture Medicinal Chemistry|December 23, 2015
Leaving the lysosome behind: novel developments in autophagy inhibitionAbigail R Solitro, Jeffrey P MacKeiganJournal of Proteome Research|May 8, 2012
Characterization of differential protein tethering at the plasma membrane in response to epidermal growth factor signalingBrendan D Looyenga, Jeffrey P MackeiganPlos One|July 3, 2013
Cytokine receptor-like factor 1 (CRLF1) protects against 6-hydroxydopamine toxicity independent of the gp130/JAK signaling pathwayBrendan D Looyenga, James Resau, Jeffrey P MacKeiganMolecular and Cellular Biology|December 16, 2003
A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and durationLeon O Murphy, Jeffrey P MacKeigan, John BlenisNature Cell Biology|May 3, 2005
Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistanceJeffrey P MacKeigan, Leon O Murphy, John BlenisMethods in Molecular Biology (Clifton, N.J.)|March 29, 2018
Patient-Derived Xenograft Models of Colorectal Cancer: Procedures for Engraftment and PropagationDanielle M Burgenske, David J Monsma, Jeffrey P MacKeiganThe Lancet. Oncology|April 13, 2010
Kinase targets in renal-cell carcinomas: reassessing the old and discovering the newKyle A Furge, Jeffrey P MacKeigan, Bin T TehChinese Journal of Cancer|August 2, 2011
Mitochondria in cancer: at the crossroads of life and deathVanessa C Fogg, Nathan J Lanning, Jeffrey P MackeiganPageof 7